Krka Temporarily Banned from Producing, Marketing Zolrix in Slovenia

Novo Mesto, 4 February - The Ljubljana District Court has issued a temporary injunction banning drug maker Krka from manufacturing and marketing in Slovenia Zolrix or other products containing the active ingredient olanzapine, the company said in a press release on Monday.